| pubmed-article:6168573 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6168573 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6168573 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:6168573 | lifeskim:mentions | umls-concept:C0005149 | lld:lifeskim |
| pubmed-article:6168573 | lifeskim:mentions | umls-concept:C0031308 | lld:lifeskim |
| pubmed-article:6168573 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:6168573 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:6168573 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:6168573 | pubmed:dateCreated | 1981-11-22 | lld:pubmed |
| pubmed-article:6168573 | pubmed:abstractText | Effect of anti-beta2-microglobulin (beta2m) antibodies was investigated on the in vitro Fc and C3 receptor dependent phagocytic capacity of human peripheral monocytes. Both rabbit and human anti-beta2m antibodies inhibit the Fc receptor-mediated phagocytosis. Anti-beta2m antibodies do not influence the spontaneous or C3b receptor-mediated ingestion. The inhibitory activity by human autoantibodies but not by rabbit anti-human beta2m antibodies was diminished when incubation was performed at 37 degrees C instead of 20 degrees C. | lld:pubmed |
| pubmed-article:6168573 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6168573 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6168573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6168573 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6168573 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:6168573 | pubmed:issn | 0165-2478 | lld:pubmed |
| pubmed-article:6168573 | pubmed:author | pubmed-author:MeréteyKK | lld:pubmed |
| pubmed-article:6168573 | pubmed:author | pubmed-author:BozsókySS | lld:pubmed |
| pubmed-article:6168573 | pubmed:author | pubmed-author:FalusAA | lld:pubmed |
| pubmed-article:6168573 | pubmed:author | pubmed-author:KávaiMM | lld:pubmed |
| pubmed-article:6168573 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6168573 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:6168573 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6168573 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6168573 | pubmed:pagination | 45-9 | lld:pubmed |
| pubmed-article:6168573 | pubmed:dateRevised | 2006-4-13 | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:meshHeading | pubmed-meshheading:6168573-... | lld:pubmed |
| pubmed-article:6168573 | pubmed:year | 1981 | lld:pubmed |
| pubmed-article:6168573 | pubmed:articleTitle | Autoantibodies specific to beta-2-microglobulin inhibit the Fc receptor-dependent phagocytosis of human monocytes. | lld:pubmed |
| pubmed-article:6168573 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6168573 | lld:pubmed |
